385 related articles for article (PubMed ID: 33483877)
1. Successful upfront cord blood transplantation for plasma cell leukemia in the first complete response after daratumumab therapy.
Ueno T; Sugio Y; Ohta T; Uehara Y; Ohno Y
Int J Hematol; 2021 Jun; 113(6):941-944. PubMed ID: 33483877
[TBL] [Abstract][Full Text] [Related]
2. Plasma Cell Leukemia with Successful Upfront Venetoclax in Combination with Allogeneic Transplantation.
Tang ASO; Ahmad Asnawi AW; Koh AZY; Chong SL; Liew PK; Selvaratnam V; Md Fauzi A; Lau NS; Tan SM
Am J Case Rep; 2023 Mar; 24():e938868. PubMed ID: 36882990
[TBL] [Abstract][Full Text] [Related]
3. A case of allogeneic hematopoietic stem cell transplantation for primary plasma cell leukemia after treatment with daratumumab.
Horisawa Y; Kondo T; Hishizawa M; Yamashita K; Takaori-Kondo A
Ann Hematol; 2020 Nov; 99(11):2699-2701. PubMed ID: 32318778
[No Abstract] [Full Text] [Related]
4. Relapsed/refractory multiple myeloma-transformed plasma-cell leukemia successfully treated with daratumumab followed by autologous stem cell transplantation.
Yang CL; Jiang NG; Zhang L; Shen K; Wu Y
Ther Adv Hematol; 2021; 12():2040620721989578. PubMed ID: 33796234
[TBL] [Abstract][Full Text] [Related]
5. Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
Mina R; Joseph NS; Kaufman JL; Gupta VA; Heffner LT; Hofmeister CC; Boise LH; Dhodapkar MV; Gleason C; Nooka AK; Lonial S
Cancer; 2019 Feb; 125(3):416-423. PubMed ID: 30332496
[TBL] [Abstract][Full Text] [Related]
6. Complete response following treatment of plasma cell leukemia with venetoclax and dexamethasone: A case report.
Vo K; Guan T; Banerjee R; Lo M; Young R; Shah N
J Oncol Pharm Pract; 2022 Jul; 28(5):1244-1248. PubMed ID: 35084252
[TBL] [Abstract][Full Text] [Related]
7. Primary Plasma Cell Leukemia: Identity Card 2016.
Musto P; Simeon V; Todoerti K; Neri A
Curr Treat Options Oncol; 2016 Apr; 17(4):19. PubMed ID: 26995215
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.
Royer B; Minvielle S; Diouf M; Roussel M; Karlin L; Hulin C; Arnulf B; Macro M; Cailleres S; Brion A; Brechignac S; Belhadj K; Chretien ML; Wetterwald M; Chaleteix C; Tiab M; Leleu X; Frenzel L; Garderet L; Choquet S; Fuzibet JG; Dauriac C; Forneker LM; Benboubker L; Facon T; Moreau P; Avet-Loiseau H; Marolleau JP
J Clin Oncol; 2016 Jun; 34(18):2125-32. PubMed ID: 27114594
[TBL] [Abstract][Full Text] [Related]
9. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
Sekiguchi Y; Shimada A; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(9):6313-22. PubMed ID: 25337285
[TBL] [Abstract][Full Text] [Related]
10. [Successful disease control of plasma cell leukemia by the treatment comprising proteasome inhibitors, followed by daratumumab, lenalidomide, and dexamethasone therapy].
Nakamura A; Yamaguchi T; Ito R; Kawakami K
Rinsho Ketsueki; 2020; 61(11):1600-1604. PubMed ID: 33298653
[TBL] [Abstract][Full Text] [Related]
11. Stringent complete remission of primary plasma cell leukemia with reduced-dose bortezomib, lenalidomide and dexamethasone: a case report and review of the literature.
Ueda S; Kubo M; Matsuura N; Matsunaga H; Kataoka S; Maeda T; Inui Y; Kawata S; Kanakura Y
Intern Med; 2013; 52(11):1235-8. PubMed ID: 23728562
[TBL] [Abstract][Full Text] [Related]
12. [Plasma cell leukemia].
Ravinet A; Bay JO; Tournilhac O
Bull Cancer; 2014 Nov; 101(11):1048-58. PubMed ID: 25418598
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab.
Salas MQ; Alahmari A; Lipton JH
Eur J Haematol; 2020 Feb; 104(2):145-147. PubMed ID: 31693245
[TBL] [Abstract][Full Text] [Related]
14. Plasma cell leukemia: concepts and management.
Liedtke M; Medeiros BC
Expert Rev Hematol; 2010 Oct; 3(5):543-9. PubMed ID: 21083471
[TBL] [Abstract][Full Text] [Related]
15. [Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis].
Jurczyszyn A; Zawirska D; Skotnicki AB
Przegl Lek; 2011; 68(6):320-5. PubMed ID: 22039670
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen.
Hoshino T; Takada S; Hatsumi N; Sakura T
Int J Hematol; 2019 Apr; 109(4):463-469. PubMed ID: 30734904
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of early relapsed plasma cells leukemia after unrelated bone marrow transplant with KRD (carfilzomib, lenalidomide and dexamethasone): a case report.].
Palazzo G
Recenti Prog Med; 2020 Mar; 111(3):160-166. PubMed ID: 32157264
[TBL] [Abstract][Full Text] [Related]
18. Successful Intrathecal Chemotherapy Combined with Radiotherapy Followed by Pomalidomide and Low-Dose Dexamethasone Maintenance Therapy for a Primary Plasma Cell Leukemia Patient.
Yamashita Y; Tamura S; Oiwa T; Kobata H; Kuriyama K; Mushino T; Murata S; Hosoi H; Nishikawa A; Hanaoka N; Sonoki T
Hematol Rep; 2017 Feb; 9(1):6986. PubMed ID: 28286633
[TBL] [Abstract][Full Text] [Related]
19. Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.
Voorhees PM; Kaufman JL; Laubach J; Sborov DW; Reeves B; Rodriguez C; Chari A; Silbermann R; Costa LJ; Anderson LD; Nathwani N; Shah N; Efebera YA; Holstein SA; Costello C; Jakubowiak A; Wildes TM; Orlowski RZ; Shain KH; Cowan AJ; Murphy S; Lutska Y; Pei H; Ukropec J; Vermeulen J; de Boer C; Hoehn D; Lin TS; Richardson PG
Blood; 2020 Aug; 136(8):936-945. PubMed ID: 32325490
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival in primary plasma cell leukemia after therapy with VAD, autologous blood stem cell transplantation and interferon-alpha.
Panizo C; Rifón J; Rodríguez-Wilhelmi P; Cuesta B; Rocha E
Acta Haematol; 1999; 101(4):193-6. PubMed ID: 10436300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
